This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Thomas Vrucina
Deputy Head Liposome Technology at Polymun Scientific


Thomas Vrucina is Deputy Head of Liposome Technology at Polymun Scientific GmbH. He possesses considerable expertise in the formulation of liposomes and LNPs, as well as in the development of the respective processes for their clinical application. He and the team at Polymun Scientific have significantly contributed to the 1st successful mRNA vaccine Comirnaty by optimizing and up-scaling the LNP process as well as by supporting clinical and early market supply of the successful Covid-19 vaccine.

Thomas Vrucina studied Bioengineering as well as Biotechnological Quality Management at the FH Campus in Vienna, Austria.

Polymun Scientific GmbH is a private Austrian company, located in Klosterneuburg, offering contract development and manufacturing of biopharmaceuticals as well as development and production of liposomal formulations. Its patented liposome technology allows efficient manufacturing of constantly high quality in small and large scale. Polymun is an EMEA-certified manufacturer conducting several own R&D projects. For more information, please visit

Agenda Sessions

  • Pioneering a Versatile LNP Production Process for mRNA Vaccines, Therapeutics, and Gene Editing - Unveiling the Proof of Concept